{"product_id":"gentaved-otic-solution","title":"Gentaved Otic Solution","description":"\u003cp\u003e \u003cspan style=\"color:black;font-weight:bold\"\u003ePrescription items are \u003c\/span\u003e \u003cspan style=\"color:red;font-weight:bold;text-decoration: underline;\"\u003eNON-RETURNABLE\u003c\/span\u003e \u003cspan style=\"color:black;font-weight:bold\"\u003e and \u003c\/span\u003e \u003cspan style=\"color:red;font-weight:bold;text-decoration: underline;\"\u003eNON REFUNDABLE\u003c\/span\u003e \u003c\/p\u003e\u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eGentaved Otic Solution\u003cbr\u003e \u003cbr\u003e Description\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/div\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eGentaVed Otic Solution is packaged in a convenient plastic squeeze bottle for easy application. Each mL of GentaVed Otic Solution contains gentamicin sulfate equivalent to 3 mg gentamicin base, betamethasone valerate equivalent to 1 mg betamethasone, 1.0 mg hydroxyethylcellulose, 2.5 mg glacial acetic acid, 200 mg purified water, 19% ethanol, 9.4 mg benzyl alcohol as preservative, 300 mg glycerin and propylene glycol q.s.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eGentaVed Otic Solution Indications\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eGentaVed Otic Solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eDosage and Administration\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eDuration of treatment will depend upon the severity of the condition and the response obtained. The duration of treatment and\/or frequency of the dosage may be reduced, but care should be taken not to discontinue therapy prematurely. \u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eOtitis externa: The external ear and ear canal should be properly cleaned and dried before treatment. Remove foreign material, debris, crusted exudates, etc., with suitable nonirritating solutions. Excessive hair should be clipped from the treatment area of the external ear. Instill 3 to 8 drops of GentaVed Otic Solution (approximately room temperature) into the ear canal twice daily for seven to fourteen days.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eContraindications\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eIf hypersensitivity to any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eConcomitant use of drugs known to induce ototoxicity should be avoided.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eThis preparation should not be used in conditions where corticosteroids are contraindicated.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eDo not administer parenteral corticosteroids during treatment with GentaVed Otic Solution.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003ePrecautions\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eThe antibiotic sensitivity of the pathogenic organism should be determined prior to the use of this preparation. Use of topical antibiotics occasionally allows overgrowth of non-susceptible bacteria, fungi, or yeasts. In these cases, treatment should be instituted with other appropriate agents as indicated. \u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eAdverse systemic reactions have been observed following the oral ingestion of some topical corticosteroid preparations. Patients should be closely observed for the usual signs of adrenocorticoid overdosage which include sodium retention, potassium loss, fluid retention, weight gains, polydipsia and\/or polyuria. Prolonged use or overdosage may produce adverse immunosuppressive effects.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eExperimentally it has been demonstrated that corticosteroids, especially at high dosage levels, may result in delayed wound healing. An increase in the incidence of osteoporosis may be noted, mainly in the elderly, with prolonged use of these compounds. Their use in older dogs during the healing stages of bone fracture is not indicated for the reason listed above.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eUse of corticosteroids, depending on dose, duration, and specific steroid, may result in inhibition of endogenous steroid production following drug withdrawal. In patients presently receiving or recently withdrawn from systemic corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in unusually stressful situations.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eGentaVed Otic Solution Caution\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eBefore instilling any medication into the ear, examine the external ear canal thoroughly to be certain the tympanic membrane is not ruptured in order to avoid the possibility of transmitting infection to the middle ear as well as damaging the cochlea or vestibular apparatus from prolonged contact. If hearing or vestibular dysfunction in noted during the course of treatment, discontinue use of GentaVed Otic Solution.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eWarning\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eClinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids can induce cleft palates in offspring when given to pregnant animals during the period of palate closure of the embryos. Other congenital anomalies including deformed forelegs, phocomelia, and anasarca have been reported in offspring of dogs which received corticosteroids during pregnancy. \u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eAvoid ingestion.\u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eSide Effects\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cdiv style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eSide effects such as SAP and SGPT enzyme elevations, weight loss, anorexia, polydipsia, and polyuria have occurred following the use of parenteral or systemic synthetic corticosteroids in dogs. Vomiting and diarrhea (occasionally bloody) have been observed in cats and dogs. \u003c\/span\u003e \u003cdiv\u003e \u003c\/div\u003e \u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e \u003cp style=\"margin: 0px; line-height: normal\"\u003e\u003cspan style=\"font-size: 10pt; color: black; margin: 0px\"\u003e\u003cspan style=\"font-family: Verdana\"\u003e\u003cspan style=\"font-size: 10pt\"\u003eCushing's Syndrome in dogs has been reported in association with prolonged or repeated steroid therapy.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Gentaved","offers":[{"title":"15ml","offer_id":42834465128536,"sku":"P00906 015","price":9.59,"currency_code":"USD","in_stock":false},{"title":"7.5ml","offer_id":42834465161304,"sku":"P00906 075","price":7.09,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0604\/1904\/7512\/files\/KV-r50110.jpg?v=1740100458","url":"https:\/\/www.petsupplies.com\/products\/gentaved-otic-solution","provider":"1800PetSupplies.com","version":"1.0","type":"link"}